The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cogent Biosciences Inc shares valued at $24,999,993 were purchased by Fairmount Funds Management LLC on Jul 10 ’25. At $9.00 per share, Fairmount Funds Management LLC acquired 2,777,777 shares. The insider’s holdings grew to 9,003,418 shares worth approximately $132.8 million following the completion of this transaction.
Also, Pinnow Cole purchased 43,750 shares, netting a total of over 332,412 in proceeds. Following the buying of shares at $7.60 each, the insider now holds 45,848 shares.
As published in their initiating research note from Raymond James on September 03, 2025, Cogent Biosciences Inc [COGT] has been a Strong buy and the price target has been revised to $30. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early March. As of December 11, 2024, Needham has decreased its “Buy” rating to a “Hold” for COGT. Earlier on February 26, 2024, Robert W. Baird downgraded its rating. Their new recommendation was “a Neutral” for COGT stock which previously was a “an Outperform”.
Analyzing COGT Stock Performance
On last trading session, Cogent Biosciences Inc [NASDAQ: COGT] rose 4.39% to $14.75. The stock’s lowest price that day was $14.025, but it reached a high of $14.77 in the same session. During the last five days, there has been a surge of approximately 10.99%. Over the course of the year, Cogent Biosciences Inc shares have jumped approximately 36.57%. Shares of the company reached a 52-week high of $14.77 on 10/02/25 and a 52-week low of $3.72 on 04/09/25.
Support And Resistance Levels for Cogent Biosciences Inc (COGT)
According to the 24-hour chart, there is a support level at 14.26, which, if violated, would cause prices to drop to 13.76. In the upper region, resistance lies at 15.01. The next price resistance is at 15.26. RSI (Relative Strength Index) is 71.04 on the 14-day chart, showing overbought technical sentiment.
Is Cogent Biosciences Inc subject to short interest?
Stocks of Cogent Biosciences Inc saw a sharp rise in short interest on 2025-09-15 jumping by 2.03 million shares to 15.04 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 13.01 million shares. A jump of 13.52% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.09 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.09.
Which companies own the most shares of Cogent Biosciences Inc (COGT)?
In terms of Cogent Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 76.93% from the previous closing price of $14.13. Analysts anticipate Cogent Biosciences Inc stock to reach 30 by 2025, with the lowest price target being 20. In spite of this, 4 analysts ranked Cogent Biosciences Inc stock as Buy at the end of 2025. On February 08, 2024, Citigroup assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
